Table 3.
Target biomarkers of JGG intervention.
| No. | Metabolites | Metabolic Pathway | Trend | |
|---|---|---|---|---|
| B/A | C/B | |||
| 1 | Sphinganine | Sphingolipid metabolism | ↓ c | ↑ b |
| 2 | 3,7-Dihydroxy-12-oxocholan-oic acid | Fat digestion and absorption | ↑ b | ↓ a |
| 3 | Dihydroceramide | Sphingolipid metabolism | ↓ b | ↑ c |
| 4 | PI (18:0/16:0) | Glycerophospholipid metabolism | ↑ a | ↓ a |
| 5 | Cervonoyl ethanolamide | N-acylethanolamine biosynthesis | ↑ c | ↓ a |
| 6 | LysoPC (22:6) | Glycerophospholipid metabolism | ↑ c | ↓ c |
| 7 | MG (0:0/18:0/0:0) | Fat digestion and absorption | ↓ b | ↑ c |
| 8 | PC (20:4/18:2) | Glycerophospholipid metabolism | ↑ c | ↓ c |
A: control group; B: model group; C: JGG (a p < 0.05; b p < 0.01; c p < 0.001).